Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Tablet Health vs WePeptideRx

Tablet Health
Graded #495

Lower grade

vs+13.799999999999997
WePeptideRx
Graded #297

Higher grade

The verdict

WePeptideRx takes it — 61.4/100 to 47.6/100.

WePeptideRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. WePeptideRx is a provider-guided telehealth platform offering compounded semaglutide and tirzepatide alongside a deep menu of peptide, hormone, hair, and sexual-wellness programs.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueWePeptideRx +3
45
48
Dose & formulationWePeptideRx +13
51
64
Clinical oversightWePeptideRx +44
37
81
Labs & monitoringWePeptideRx +3
50
53
FulfillmentWePeptideRx +10
57
67
Contract termsEven
55
55
Tablet Health · left barWePeptideRx · right bar

The numbers

MetricTablet HealthWePeptideRx
WeighScore47.6/10061.4/100
GradeCC
Scorecard rank#495#297
SemaglutideNot disclosed$249/mo (compounded)
TirzepatideNot disclosed$249/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Tablet Health

Graded #495 · C

Strengths

  • LegitScript Certified
  • Four named compounding pharmacy partners (Pharmacy Hub, Epiq Scripts, Dr. TelX, Emerad), none with FDA warning letters
  • Oral GLP-1 option for both semaglutide and tirzepatide — uncommon in compounded telehealth
  • Mid-tier pricing starting $179–$299/mo across all four product variants
  • No commitment — cancel anytime

Where it loses points

  • States served not published — you must complete the intake quiz to learn eligibility
  • No founder, CEO, medical director, or pharmacist-in-charge named anywhere
  • No BBB profile found
  • Its Queens NYC pharmacy is 'opening soon' — all dispensing currently routes through external partners
  • FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database
WePeptideRx

Graded #297 · C

Strengths

  • Pre-mixed ready-to-inject delivery skips the vial reconstitution and sharps hassle of most compounded providers
  • Microdose protocols (0.05–0.25 mg sema, 0.5–2.5 mg tirz) suit ultra-low-dose maintenance patients — uncommon in DTC
  • 12+ programs under one platform — GLP-1 plus longevity, sexual wellness, and hair
  • Physical Boca Raton address, phone, and business hours listed
  • LegitScript Certified and publishes the FDA disclaimer

Where it loses points

  • Pharmacy partner not named
  • 48-state claim, but the specific state list isn't shown on the homepage
  • Medical director not named on the homepage
  • Telemedicine is outsourced to a third-party provider network rather than in-house staff
  • Corporate legal entity and arbitration venue not disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard